Milone Luca, Strong Vivian, Gagner Michel
Department of Surgery, New York Presbyterian Hospital, Weill College of Medicine of Cornell University, New York, NY 10021, USA.
Obes Surg. 2005 May;15(5):612-7. doi: 10.1381/0960892053923833.
The treatment of patients with a BMI > or =50 kg/m2 is still controversial. Given the many co-morbidities and oftentimes fragile health of super-obese patients, surgeons experienced in bariatrics often advocate a less invasive first stage operation for these patients. This allows them enough weight loss to support a more major second-stage operation such as a gastric bypass or a biliopancreatic diversion/duodenal switch. Thus, the aim of this study was to compare laparoscopic sleeve gastrectomy (LSG) and the BioEnterics intragastric balloon (BIB) as a first-stage procedure for effective initial weight loss before more definitive surgery.
20 patients (13 males and 7 females) who underwent LSG from May 2001 to December 2002 were compared with 57 patients (33 males and 24 females) obtained as historical controls from two large series who underwent BIB. Patients were evaluated at 6 months in terms of: weight, BMI, percent of excess weight loss (%EWL) and change in BMI.
There were no differences between groups for age, weight and BMI. There were no complications for patients under-going the LSG. For patients undergoing BIB, 4 patients (7%) had the balloon removed due to intolerance. The mean weight loss for patients undergoing LSG and BIB at 6 months was 45.5 vs 22.3 kg respectively, and the %EWL was 35 for LSG vs 24 for BIB. BMI decreased respectively from 69 to 53 for the LSG group and from 59 to 51 for the BIB group. Weight loss decreased co-morbidities in 90% of patients after both procedures.
Patients undergoing a LSG showed a faster and greater weight loss than those using a BIB at 6 months. Moreover, LSG is a safe procedure, with reproducible results, in contrast to the BIB which was tolerated by 93% of patients. The results indicate that both mean weight loss and %EWL were better in the LSG group, and that BMI decreased substantially more in the LSG group as well. Although the BIB procedure shows efficacy in reducing weight, the LSG group does so faster and to a greater amount, thus suggesting that this may be a superior procedure as a first stage for super-obesity.
体重指数(BMI)≥50kg/m²患者的治疗仍存在争议。鉴于超级肥胖患者存在多种合并症且健康状况往往较差,经验丰富的减重外科医生通常主张为这些患者实施侵入性较小的一期手术。这能使他们减轻足够体重,以支持后续更大型的二期手术,如胃旁路手术或胆胰分流/十二指肠转位手术。因此,本研究旨在比较腹腔镜袖状胃切除术(LSG)和BioEnterics胃内球囊(BIB)作为一期手术在更确定性手术前实现有效初始体重减轻的效果。
将2001年5月至2002年12月接受LSG的20例患者(13例男性,7例女性)与从两个大型系列研究中选取的57例接受BIB的历史对照患者(33例男性,24例女性)进行比较。在6个月时对患者进行评估,评估指标包括:体重、BMI、超重减轻百分比(%EWL)和BMI变化。
两组患者在年龄、体重和BMI方面无差异。接受LSG手术的患者未出现并发症。接受BIB手术的患者中,4例(7%)因不耐受而取出球囊。接受LSG和BIB手术的患者在6个月时的平均体重减轻分别为45.5kg和22.3kg,LSG组的%EWL为35%,BIB组为24%。LSG组的BMI从69降至53,BIB组从59降至51。两种手术术后,90%的患者体重减轻使合并症有所改善。
接受LSG手术的患者在6个月时体重减轻速度更快、幅度更大。此外,与93%患者能耐受的BIB相比,LSG是一种安全的手术,结果具有可重复性。结果表明,LSG组的平均体重减轻和%EWL均更好,且LSG组的BMI下降幅度也更大。虽然BIB手术在减轻体重方面显示出疗效,但LSG组减重更快、幅度更大,因此表明作为超级肥胖的一期手术,LSG可能是一种更优的手术方式。